BioCentury
ARTICLE | Clinical News

Diazepam nasal spray regulatory update

December 16, 2013 8:00 AM UTC

Acorda said it submitted an NDA to FDA for its diazepam nasal spray to treat acute repetitive seizures in epileptics. The company submitted the product under section 505(b)(2) of the Food, Drug and Co...